l-Arginine and COVID-19: An Update

Nutrients. 2021 Nov 5;13(11):3951. doi: 10.3390/nu13113951.

Abstract

l-Arginine is involved in many different biological processes and recent reports indicate that it could also play a crucial role in the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Herein, we present an updated systematic overview of the current evidence on the functional contribution of L-Arginine in COVID-19, describing its actions on endothelial cells and the immune system and discussing its potential as a therapeutic tool, emerged from recent clinical experimentations.

Keywords: COVID-19; ROS; SARS-CoV-2; T cells; antiviral therapies; arginine; coronavirus; cytokine storm; endothelium; immune response; immunity; inflammation; nitric oxide; nitrosylation; oxidative stress; viral infections.

Publication types

  • Review

MeSH terms

  • Animals
  • Arginine / metabolism*
  • Arginine / therapeutic use
  • COVID-19 / immunology
  • COVID-19 / metabolism*
  • COVID-19 / virology
  • COVID-19 Drug Treatment
  • Endothelial Cells / drug effects
  • Endothelial Cells / immunology
  • Endothelial Cells / metabolism*
  • Endothelial Cells / virology
  • Host-Pathogen Interactions
  • Humans
  • Immune System / drug effects
  • Immune System / immunology
  • Immune System / metabolism*
  • Immune System / virology
  • Nitric Oxide / metabolism
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / pathogenicity*

Substances

  • Nitric Oxide
  • Arginine